RIA is home to bright, passionate scientists whose work covers a
wide range of addiction-related topics. They work in a culture of
scientific and organizational support that nurtures creativity and
We share knowledge with other researchers, treatment providers,
legislators and the public to aid understanding of
addiction-related issues through regular news releases, seminars,
conferences and our Expert Summaries series.
Our Addiction Treatment Services (ATS) is the only treatment
program in New York State designed specifically for clinical
research and plays a fundamental role in the Institute’s
ability to test, apply and monitor innovative treatment
Rina Das Eiden, PhD, was one of only four scientists to win UB's
and Translational Science Award for the most promising
advances in clinical research. Eiden was honored for her research
on children of parents with alcohol problems.
Using Ritalin without a prescription is a growing problem among
college students who consider it a so-called 'study enhancer.'
Panayotis (Peter) Thanos, PhD, warns against the long-range risks
of nonprescription use in Futurity.
Kurt Dermen, PhD, and Christopher Barrick, PhD, are part of a
team of researchers who received a $1.92
million grant to train new behavioral health practitioners
and combat the opioid epidemic in Western New York.
RIA Director Kenneth E. Leonard, PhD, is collaborating with a
group of UB clinicians in training health care practitioners across
New York State in medication-assisted
treatment (MAT) of opioid addiction.